RA Capital Management

Ra Capital Management as of Sept. 30, 2020

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 70 positions in its portfolio as reported in the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A S Sponsored Adr (ASND) 16.7 $912M 5.9M 154.32
Forma Therapeutics Hldgs SHS 8.2 $449M 9.0M 49.84
Chemocentryx 4.8 $265M 4.8M 54.80
Vaxcyte (PCVX) 4.8 $261M 5.3M 49.38
Tg Therapeutics (TGTX) 4.3 $236M 8.8M 26.76
Nkarta (NKTX) 3.1 $169M 5.6M 30.06
Axsome Therapeutics (AXSM) 2.7 $145M 2.0M 71.25
Phathom Pharmaceuticals (PHAT) 2.6 $140M 3.8M 36.67
Seres Therapeutics (MCRB) 2.5 $135M 4.8M 28.31
Novavax Com New (NVAX) 2.4 $130M 1.2M 108.35
89bio (ETNB) 2.2 $122M 4.7M 25.66
Rhythm Pharmaceuticals (RYTM) 2.0 $111M 5.1M 21.67
Macrogenics (MGNX) 2.0 $110M 4.4M 25.19
Eidos Therapeutics 2.0 $109M 2.2M 50.53
Iteos Therapeutics (ITOS) 2.0 $109M 4.4M 24.67
Zogenix Com New 1.8 $98M 5.5M 17.93
Adverum Biotechnologies 1.8 $97M 9.4M 10.30
Adaptimmune Therapeutics Sponds Adr (ADAP) 1.7 $90M 11M 7.98
Trillium Therapeutics Com New 1.6 $88M 6.2M 14.21
Arvinas Ord (ARVN) 1.6 $87M 3.7M 23.61
Retrophin 1.6 $86M 4.6M 18.46
Kala Pharmaceuticals 1.5 $82M 11M 7.50
Black Diamond Therapeutics (BDTX) 1.4 $78M 2.6M 30.23
Legend Biotech Corp Sponsored Ads (LEGN) 1.4 $74M 2.4M 30.87
Igm Biosciences (IGMS) 1.3 $73M 983k 73.81
Keros Therapeutics (KROS) 1.3 $72M 1.9M 38.57
Vaxart Com New (VXRT) 1.3 $72M 11M 6.65
Wave Life Sciences SHS (WVE) 1.2 $66M 7.8M 8.49
Pmv Pharmaceuticals (PMVP) 1.1 $61M 1.7M 35.50
Dyne Therapeutics (DYN) 1.0 $57M 2.8M 20.19
Inozyme Pharma (INZY) 1.0 $53M 2.0M 26.29
Geron Corporation (GERN) 1.0 $52M 30M 1.74
Akouos 1.0 $52M 2.3M 22.87
Orchard Therapeutics Ads 0.9 $51M 12M 4.11
Cardiff Oncology (CRDF) 0.9 $47M 3.3M 14.19
Relay Therapeutics (RLAY) 0.8 $43M 1.0M 42.59
Inhibrx 0.7 $38M 2.1M 18.00
Alector (ALEC) 0.7 $38M 3.6M 10.54
Crinetics Pharmaceuticals In (CRNX) 0.7 $37M 2.3M 15.67
Arcutis Biotherapeutics (ARQT) 0.6 $34M 1.2M 29.30
Ardelyx (ARDX) 0.6 $33M 6.3M 5.25
Verona Pharma Sponsored Ads (VRNA) 0.6 $32M 5.1M 6.24
Relmada Therapeutics (RLMD) 0.5 $29M 781k 37.62
Scpharmaceuticals (SCPH) 0.5 $26M 3.5M 7.45
ImmunoGen 0.5 $25M 7.0M 3.60
Larimar Therapeutics (LRMR) 0.4 $23M 1.5M 15.17
Sutro Biopharma (STRO) 0.4 $21M 2.1M 10.05
Ocular Therapeutix (OCUL) 0.4 $21M 2.7M 7.61
Pandion Therapeutics 0.4 $20M 1.8M 11.46
Prevail Therapeutics Ord 0.4 $20M 1.9M 10.18
Concert Pharmaceuticals I equity 0.3 $18M 1.9M 9.82
Satsuma Pharmaceuticals Ord 0.3 $18M 4.7M 3.89
Milestone Pharmaceuticals (MIST) 0.3 $18M 2.4M 7.32
Syndax Pharmaceuticals (SNDX) 0.3 $15M 1.0M 14.76
Bctg Acquisition Corp 0.2 $13M 1.3M 10.36
Repare Therapeutics Ord (RPTX) 0.2 $13M 409k 30.77
Fs Dev Corp Com Cl A 0.2 $11M 1.0M 11.20
Arya Sciences Acquisition Com Cl A 0.2 $11M 1.0M 10.81
Verastem 0.2 $9.8M 8.1M 1.21
Solid Biosciences 0.2 $9.3M 4.6M 2.03
Lyra Therapeutics (LYRA) 0.2 $9.3M 816k 11.34
Arya Sciences Acquisition Corp Unit 06/09/2027 0.1 $7.7M 700k 11.00
Galera Therapeutics (GRTX) 0.1 $7.5M 825k 9.04
Health Sciences Acq Corp 2 Ord Shs 0.1 $6.9M 625k 11.00
Celldex Therapeutics Com New (CLDX) 0.1 $5.2M 353k 14.83
Imara 0.1 $5.1M 250k 20.34
Passage Bio (PASG) 0.1 $4.2M 323k 13.11
X4 Pharmaceuticals (XFOR) 0.1 $3.8M 560k 6.77
Essa Pharma Com New (EPIX) 0.1 $3.2M 470k 6.90
Ovid Therapeutics (OVID) 0.0 $1.6M 285k 5.74